Gadolinium-based contrast brokers (GBCAs) are widely Employed in magnetic resonance imaging (MRI) to improve the visibility of blood vessels, tumors, inflammation, as well as other interior constructions. Whilst usually considered Harmless, worries about GBCA toxicity have emerged over the past 20 years—especially in people with impaired kidney o